Parameter
| Biomarker | RET (fusion) | Full name | Rearranged during transfection fusions | Molecular Type | Nucleic acids (DNA synthesis) |
|---|---|---|---|---|---|
| Molecular Formula | Targeted therapy options | Molecular Weight | Core Functional Dimensions | ||
| Disease | Cholangiocarcinoma (CCA) | Disease Subtypes | / | ||
| Organ | Bile duct/Liver | Test Sample / Technology Platform | Tissue/Plasma (NGS) | ||
| Pathobiological Mechanisms | Fusions activate RET signaling and promote tumor proliferation and angiogenesis | ||||
| Clinical Availability Status | The validation; Some patients carry | ||||
| Notes and Dynamics | |||||